| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.16e-19 | 114 | 115 | 17 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 5.14e-19 | 124 | 115 | 17 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 2.95e-18 | 137 | 115 | 17 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 CTSF USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 4.64e-17 | 192 | 115 | 18 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 CTSF USP17L4 USP17L2 USP17L1 PITRM1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 6.10e-09 | 654 | 115 | 19 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | HIVEP2 VEZF1 ZNF391 SOX30 ZNF195 ZNF880 CHD7 ZNF362 EBF1 SIX4 ZNF251 CASZ1 ZNF677 ZNF263 DMRT2 ZNF256 ZNF667 ZNF471 NFAT5 ZNF281 PRDM16 SMAD5 ZNF574 ZNF124 | 2.39e-06 | 1459 | 115 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | HIVEP2 SOX30 ZNF195 ZNF880 CHD7 ZNF362 EBF1 SIX4 ZNF251 ZNF677 ZNF263 DMRT2 ZNF256 ZNF667 ZNF471 NFAT5 ZNF281 PRDM16 SMAD5 ZNF574 | 2.65e-05 | 1244 | 115 | 20 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | HIVEP2 SOX30 ZNF195 ZNF880 CHD7 ZNF362 EBF1 SIX4 ZNF251 ZNF677 ZNF263 DMRT2 ZNF256 ZNF667 ZNF471 NFAT5 ZNF281 PRDM16 SMAD5 ZNF574 | 3.59e-05 | 1271 | 115 | 20 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HIVEP2 VEZF1 ZNF391 SOX30 ZNF195 ZNF880 EBF1 SIX4 ZNF251 CASZ1 ZNF677 ZNF263 DMRT2 ZNF256 ZNF471 NFAT5 ZNF281 PRDM16 SMAD5 ZNF574 ZNF124 | 5.09e-05 | 1412 | 115 | 21 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | HIVEP2 VEZF1 SOX30 EBF1 SIX4 CASZ1 DMRT2 NFAT5 PRDM16 ZNF574 | 1.49e-03 | 560 | 115 | 10 | GO:0001228 |
| GeneOntologyMolecularFunction | SMAD binding | 1.54e-03 | 86 | 115 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | HIVEP2 VEZF1 SOX30 EBF1 SIX4 CASZ1 DMRT2 NFAT5 PRDM16 ZNF574 | 1.61e-03 | 566 | 115 | 10 | GO:0001216 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 2.97e-19 | 125 | 114 | 17 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 3.53e-18 | 144 | 114 | 17 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 UBR4 USP17L24 SMURF1 USP17L5 AMBRA1 MARCHF7 USP17L10 ZMIZ1 USP17L18 USP31 USP17L17 ANAPC1 TRIM8 USP17L3 USP17L15 USP17L8 USP17L13 | 1.10e-09 | 1009 | 114 | 24 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 UBR4 USP17L24 SMURF1 USP17L5 AMBRA1 MARCHF7 USP17L10 ZMIZ1 USP17L18 USP31 USP17L17 ANAPC1 TRIM8 USP17L3 USP17L15 USP17L8 USP17L13 | 3.76e-09 | 1074 | 114 | 24 | GO:0043687 |
| HumanPheno | Narrow mouth | 1.34e-05 | 234 | 26 | 8 | HP:0000160 | |
| HumanPheno | Abnormality of mouth size | ASXL1 HIVEP2 CENPF CHD7 ZMIZ1 JMJD1C CASZ1 RTL1 KCNN3 PRDM16 | 2.30e-05 | 425 | 26 | 10 | HP:0011337 |
| MousePheno | increased thymus weight | 7.49e-06 | 24 | 75 | 4 | MP:0004955 | |
| MousePheno | increased trophectoderm apoptosis | 8.15e-06 | 8 | 75 | 3 | MP:0012119 | |
| MousePheno | abnormal vitelline vascular remodeling | 1.83e-05 | 61 | 75 | 5 | MP:0004076 | |
| MousePheno | abnormal artery development | 7.79e-05 | 133 | 75 | 6 | MP:0003410 | |
| MousePheno | abnormal extraembryonic tissue physiology | 9.16e-05 | 345 | 75 | 9 | MP:0004264 | |
| MousePheno | dilated dorsal aorta | 1.14e-04 | 18 | 75 | 3 | MP:0004068 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L18 USP17L17 USP17L3 USP17L13 | 9.28e-22 | 16 | 112 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L18 USP17L17 USP17L3 USP17L13 | 9.28e-22 | 16 | 112 | 11 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L8 USP17L13 | 2.24e-21 | 71 | 112 | 16 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L8 USP17L13 | 2.24e-21 | 71 | 112 | 16 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L8 USP17L13 | 2.87e-21 | 72 | 112 | 16 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L8 USP17L13 | 2.87e-21 | 72 | 112 | 16 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L8 USP17L13 | 2.87e-21 | 72 | 112 | 16 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L8 USP17L13 | 3.68e-20 | 66 | 112 | 15 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP31 USP17L17 USP17L3 USP17L8 USP17L13 | 9.70e-20 | 70 | 112 | 15 | PS00972 |
| Domain | zf-C2H2 | BNC2 HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 CASZ1 ZNF677 ZNF106 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 2.85e-08 | 693 | 112 | 19 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | BNC2 HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 CASZ1 ZNF677 ZNF106 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 1.64e-07 | 775 | 112 | 19 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | BNC2 HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 CASZ1 ZNF677 ZNF106 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 1.71e-07 | 777 | 112 | 19 | PS00028 |
| Domain | Znf_C2H2-like | BNC2 HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 CASZ1 ZNF677 ZNF106 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 2.48e-07 | 796 | 112 | 19 | IPR015880 |
| Domain | Znf_C2H2 | BNC2 HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 CASZ1 ZNF677 ZNF106 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 2.94e-07 | 805 | 112 | 19 | IPR007087 |
| Domain | ZnF_C2H2 | BNC2 HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 CASZ1 ZNF677 ZNF106 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 3.12e-07 | 808 | 112 | 19 | SM00355 |
| Domain | - | HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 ZNF677 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 2.89e-06 | 679 | 112 | 16 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 ZNF677 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 3.82e-06 | 694 | 112 | 16 | IPR013087 |
| Domain | zf-C2H2_6 | ZNF391 ZNF195 ZNF880 ZNF251 ZNF677 ZNF256 ZNF667 PRDM16 ZNF574 | 1.15e-04 | 314 | 112 | 9 | PF13912 |
| Domain | KRAB | ZNF195 ZNF880 ZNF251 ZNF677 ZNF263 ZNF256 ZNF667 ZNF471 ZNF124 | 3.06e-04 | 358 | 112 | 9 | PS50805 |
| Domain | KRAB | ZNF195 ZNF880 ZNF251 ZNF677 ZNF263 ZNF256 ZNF667 ZNF471 ZNF124 | 3.06e-04 | 358 | 112 | 9 | PF01352 |
| Domain | KRAB | ZNF195 ZNF880 ZNF251 ZNF677 ZNF263 ZNF256 ZNF667 ZNF471 ZNF124 | 3.82e-04 | 369 | 112 | 9 | SM00349 |
| Domain | KRAB | ZNF195 ZNF880 ZNF251 ZNF677 ZNF263 ZNF256 ZNF667 ZNF471 ZNF124 | 3.90e-04 | 370 | 112 | 9 | IPR001909 |
| Domain | BRK | 5.26e-04 | 6 | 112 | 2 | SM00592 | |
| Domain | BRK_domain | 5.26e-04 | 6 | 112 | 2 | IPR006576 | |
| Domain | BRK | 5.26e-04 | 6 | 112 | 2 | PF07533 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 4.27e-24 | 45 | 74 | 15 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 4.96e-14 | 191 | 74 | 15 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 ASXL1 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 3.29e-13 | 262 | 74 | 16 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 4.25e-13 | 221 | 74 | 15 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 ASXL1 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 2.50e-12 | 299 | 74 | 16 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 SPTBN5 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 6.37e-12 | 318 | 74 | 16 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 ASXL1 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 LAMB2 USP17L5 USP17L10 ITIH2 USP17L18 SPTBN5 PPARGC1A USP17L17 SEC16A USP17L3 USP17L15 USP17L8 USP17L13 | 1.45e-05 | 1475 | 74 | 21 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 ASXL1 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 ITIH2 USP17L18 SPTBN5 USP17L17 SEC16A USP17L3 USP17L15 USP17L8 USP17L13 | 7.22e-05 | 1389 | 74 | 19 | MM15307 |
| Pathway | REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION | 2.69e-04 | 5 | 74 | 2 | M45010 | |
| Pathway | WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE | 2.94e-04 | 25 | 74 | 3 | M39665 | |
| Pathway | WP_FTO_OBESITY_VARIANT_MECHANISM | 7.46e-04 | 8 | 74 | 2 | M39356 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.27e-33 | 21 | 115 | 15 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.27e-33 | 21 | 115 | 15 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.27e-33 | 21 | 115 | 15 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.27e-33 | 21 | 115 | 15 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.27e-33 | 21 | 115 | 15 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.27e-33 | 21 | 115 | 15 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 3.99e-33 | 22 | 115 | 15 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 3.04e-32 | 24 | 115 | 15 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 7.59e-32 | 25 | 115 | 15 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 7.65e-32 | 33 | 115 | 16 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 20403174 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.44e-31 | 34 | 115 | 16 | 21448158 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.79e-31 | 26 | 115 | 15 | 35816173 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 2.65e-31 | 35 | 115 | 16 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 2.65e-31 | 35 | 115 | 16 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 4.75e-31 | 36 | 115 | 16 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 8.35e-31 | 37 | 115 | 16 | 20228808 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.78e-30 | 29 | 115 | 15 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 4.89e-26 | 50 | 115 | 15 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 4.27e-16 | 10 | 115 | 7 | 24207026 | |
| Pubmed | 2.80e-15 | 12 | 115 | 7 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.21e-14 | 14 | 115 | 7 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 1.75e-13 | 19 | 115 | 7 | 28067227 | |
| Pubmed | USP17L7 USP17L21 SERPINA3 USP17L4 MYOT USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 9.41e-11 | 674 | 115 | 17 | 37196079 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP31 USP17L3 USP17L15 USP17L8 | 2.94e-10 | 81 | 115 | 8 | 12838346 | |
| Pubmed | ASXL1 PITRM1 VEZF1 UBR4 MRPL10 CHD7 ZMIZ1 SIX4 ANKHD1 JMJD1C KIAA1671 SEC16A UNK GIGYF2 EIF3A QSER1 CABIN1 ZNF471 ZNF281 PRDM16 SMAD5 | 8.77e-09 | 1429 | 115 | 21 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP2 CHD7 ZMIZ1 SIX4 KIAA1671 ZNF263 TNRC18 SEC16A QSER1 ZNF281 PRDM16 | 2.64e-08 | 351 | 115 | 11 | 38297188 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 1.41e-07 | 4 | 115 | 3 | 22984479 | |
| Pubmed | TANC2 RALGAPB FAM83B KIAA1671 ANAPC1 TJP1 SEC16A UNK GIGYF2 PATJ XPR1 | 2.94e-07 | 446 | 115 | 11 | 24255178 | |
| Pubmed | LRWD1 VEZF1 RALGAPB LAMB2 CHD7 SIX4 ANKHD1 CASZ1 KIAA2013 FAM83B KIAA1671 ANAPC1 UNK EIF3A PATJ ZNF281 ZNF574 XPR1 DUSP11 | 4.68e-07 | 1497 | 115 | 19 | 31527615 | |
| Pubmed | 5.53e-07 | 48 | 115 | 5 | 16421571 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 LRWD1 HIVEP2 UBR4 LAMB2 AMBRA1 ANKHD1 ADGRA2 CASZ1 KIAA2013 PCNX2 ZNF263 TNRC18 SEC16A CABIN1 PRDM16 | 7.61e-07 | 1105 | 115 | 16 | 35748872 |
| Pubmed | MIER2 TANC2 ARHGEF28 JMJD1C CASZ1 KIAA2013 TRIM66 TNRC18 ATRNL1 EIF3A PRDM16 | 7.86e-07 | 493 | 115 | 11 | 15368895 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 HIVEP2 ARHGEF28 CEP85L RALGAPB PAK6 FAM83B KIAA1671 USP31 ZNF106 TJP1 SEC16A GIGYF2 PATJ | 1.03e-06 | 861 | 115 | 14 | 36931259 |
| Pubmed | CENPF UBR4 CHD7 ZMIZ1 ANKHD1 JMJD1C KIAA1671 ANAPC1 SEC16A GIGYF2 | 1.37e-06 | 418 | 115 | 10 | 34709266 | |
| Pubmed | 1.53e-06 | 242 | 115 | 8 | 34011540 | ||
| Pubmed | 2.53e-06 | 116 | 115 | 6 | 30804394 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 4.39e-06 | 197 | 115 | 7 | 20811636 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIER2 LRWD1 VEZF1 CHD9 CHD7 ZNF362 JMJD1C CASZ1 QSER1 CABIN1 ZNF281 | 5.87e-06 | 608 | 115 | 11 | 36089195 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.43e-06 | 398 | 115 | 9 | 35016035 | |
| Pubmed | 8.56e-06 | 83 | 115 | 5 | 28794006 | ||
| Pubmed | 1.05e-05 | 225 | 115 | 7 | 12168954 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11872753 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18725400 | ||
| Pubmed | 2.57e-05 | 104 | 115 | 5 | 9205841 | ||
| Pubmed | 2.85e-05 | 263 | 115 | 7 | 34702444 | ||
| Pubmed | 3.22e-05 | 268 | 115 | 7 | 33640491 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIVEP2 RALGAPB SMURF1 CHD9 ZNF362 ZMIZ1 JMJD1C CASZ1 PCNX2 KIAA1671 TNRC18 PTPRJ TJP1 QSER1 PATJ NFAT5 | 3.23e-05 | 1489 | 115 | 16 | 28611215 |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19567523 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 28824327 | ||
| Pubmed | Transcriptional control of brown fat determination by PRDM16. | 3.24e-05 | 3 | 115 | 2 | 17618855 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 14711801 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 22670624 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 22033933 | ||
| Pubmed | Imprinted gene dosage is critical for the transition to independent life. | 3.85e-05 | 20 | 115 | 3 | 22326222 | |
| Pubmed | 4.44e-05 | 282 | 115 | 7 | 23667531 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 4.90e-05 | 119 | 115 | 5 | 28625976 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 17676934 | ||
| Pubmed | TANC2 AMBRA1 CHD9 ZNF362 ANKHD1 KIAA1671 TRIM66 ANAPC1 CAPRIN2 SEC16A ZNF281 PRDM16 ZNF574 | 8.46e-05 | 1116 | 115 | 13 | 31753913 | |
| Pubmed | 9.11e-05 | 549 | 115 | 9 | 38280479 | ||
| Pubmed | EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. | 1.08e-04 | 5 | 115 | 2 | 22068036 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 19332538 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 25266661 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 29934521 | ||
| Pubmed | Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. | 1.08e-04 | 5 | 115 | 2 | 18483224 | |
| Pubmed | Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. | 1.08e-04 | 5 | 115 | 2 | 18641638 | |
| Pubmed | Hgs physically interacts with Smad5 and attenuates BMP signaling. | 1.08e-04 | 5 | 115 | 2 | 16516194 | |
| Pubmed | 1.21e-04 | 29 | 115 | 3 | 23499423 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.29e-04 | 146 | 115 | 5 | 23892456 | |
| Pubmed | 1.30e-04 | 233 | 115 | 6 | 37704626 | ||
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 1.31e-04 | 450 | 115 | 8 | 16751776 | |
| Pubmed | Mouse embryo geometry drives formation of robust signaling gradients through receptor localization. | 1.61e-04 | 6 | 115 | 2 | 31586065 | |
| Pubmed | 1.61e-04 | 6 | 115 | 2 | 17397395 | ||
| Pubmed | 1.61e-04 | 6 | 115 | 2 | 24828823 | ||
| Pubmed | 1.66e-04 | 733 | 115 | 10 | 34672954 | ||
| Pubmed | 2.25e-04 | 7 | 115 | 2 | 12370310 | ||
| Pubmed | 2.79e-04 | 638 | 115 | 9 | 31182584 | ||
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 29155075 | ||
| Pubmed | Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. | 3.00e-04 | 8 | 115 | 2 | 10482238 | |
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 22006950 | ||
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 20484049 | ||
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 11278251 | ||
| Pubmed | ARHGEF28 RALGAPB AMBRA1 ANKHD1 JMJD1C GIGYF2 QSER1 PATJ ZNF574 | 3.19e-04 | 650 | 115 | 9 | 38777146 | |
| Pubmed | TANC2 CENPF UBR4 CHD7 ZNF263 ANAPC1 TJP1 SEC16A GIGYF2 QSER1 CABIN1 | 3.60e-04 | 963 | 115 | 11 | 28671696 | |
| Pubmed | 3.60e-04 | 808 | 115 | 10 | 20412781 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.76e-04 | 184 | 115 | 5 | 32908313 | |
| Pubmed | 3.84e-04 | 9 | 115 | 2 | 20063299 | ||
| Pubmed | The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. | 3.84e-04 | 9 | 115 | 2 | 19295126 | |
| Pubmed | 3.84e-04 | 9 | 115 | 2 | 20007998 | ||
| Pubmed | 3.84e-04 | 9 | 115 | 2 | 15123739 | ||
| Interaction | PHF21A interactions | CENPF UBR4 CHD7 ZMIZ1 ANKHD1 JMJD1C KIAA1671 ANAPC1 SEC16A GIGYF2 EXOC1 | 2.81e-06 | 343 | 110 | 11 | int:PHF21A |
| Interaction | EGR2 interactions | 4.48e-06 | 171 | 110 | 8 | int:EGR2 | |
| Interaction | SOX7 interactions | 5.76e-06 | 82 | 110 | 6 | int:SOX7 | |
| Interaction | FBXO38 interactions | 1.48e-05 | 145 | 110 | 7 | int:FBXO38 | |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13 | 8.12e-15 | 79 | 115 | 10 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13 | 2.73e-10 | 222 | 115 | 10 | chr4p16 |
| Cytoband | 8p23.1 | 2.69e-06 | 154 | 115 | 6 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 2.91e-05 | 234 | 115 | 6 | chr8p23 | |
| Cytoband | 5q31 | 2.08e-04 | 115 | 115 | 4 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 5.29e-04 | 147 | 115 | 4 | chr15q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 9.56e-04 | 298 | 115 | 5 | chr5q31 | |
| Cytoband | 19q13.43 | 1.39e-03 | 87 | 115 | 3 | 19q13.43 | |
| Cytoband | 10q26 | 1.52e-03 | 23 | 115 | 2 | 10q26 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 HIVEP2 VEZF1 ZNF391 ZNF195 ZNF880 ZNF362 ZNF251 CASZ1 ZNF677 ZNF106 ZNF263 ZNF256 ZNF667 ZNF471 ZNF281 PRDM16 ZNF574 ZNF124 | 3.08e-11 | 718 | 72 | 19 | 28 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.85e-20 | 86 | 112 | 15 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 1.22e-18 | 112 | 112 | 15 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 CAPRIN2 USP17L3 USP17L15 USP17L8 USP17L13 | 9.94e-18 | 160 | 112 | 16 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 ANGPT4 USP17L3 ZNF281 USP17L15 USP17L8 USP17L13 | 2.32e-09 | 647 | 112 | 17 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 CEP85L USP17L20 USP17L11 SMURF1 USP17L5 USP17L10 ADGRA2 PAIP1 USP17L18 USP17L17 USP17L3 UNK DKKL1 USP17L15 USP17L8 USP17L13 | 3.27e-08 | 1198 | 112 | 21 | MM1062 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L4 THEMIS USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 PTPRJ USP17L17 USP17L3 NFAT5 ZNF281 USP17L15 USP17L8 USP17L13 | 1.37e-07 | 1072 | 112 | 19 | MM1031 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 LRWD1 USP17L2 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 KIAA2013 USP17L18 USP17L17 ANGPT4 CAPRIN2 USP17L3 ZNF281 USP17L15 USP17L8 USP17L13 | 2.32e-07 | 1226 | 112 | 20 | MM979 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 7.92e-05 | 240 | 112 | 7 | M39236 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-07 | 188 | 109 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.86e-07 | 198 | 109 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.93e-06 | 177 | 109 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.78e-06 | 104 | 109 | 5 | 1360c9fcb9a68b385aa28dabd0715e71c4867a5b | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 6.55e-06 | 186 | 109 | 6 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 186 | 109 | 6 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-06 | 190 | 109 | 6 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.85e-06 | 192 | 109 | 6 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.09e-06 | 193 | 109 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 194 | 109 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 195 | 109 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-06 | 196 | 109 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 150 | 109 | 5 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-05 | 151 | 109 | 5 | 2dc132895609e4efe17954e31f53d9c1ccf256ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 151 | 109 | 5 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-05 | 151 | 109 | 5 | 22afd8201eff8471da3456be065f2790de5e4bfe | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 164 | 109 | 5 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-05 | 164 | 109 | 5 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 164 | 109 | 5 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 164 | 109 | 5 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 164 | 109 | 5 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-05 | 166 | 109 | 5 | 6fe8db8d45177a78605681f22e04fa8d0594f2df | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.18e-05 | 170 | 109 | 5 | 6de3778e8257c3330db0780c59238ca501fe5059 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.18e-05 | 170 | 109 | 5 | 60887da674ef1a735bad618235608312d8de63d3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-05 | 179 | 109 | 5 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.09e-05 | 180 | 109 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.75e-05 | 183 | 109 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.97e-05 | 184 | 109 | 5 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 8.97e-05 | 184 | 109 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.20e-05 | 185 | 109 | 5 | 9878392d79734ab5bb977d7f4f5e2e079b9a5353 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.20e-05 | 185 | 109 | 5 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | 75258d88e23112fd1f0f7c71ef0366abb400d33e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 186 | 109 | 5 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.50e-05 | 97 | 109 | 4 | 489f5e12eb67b1850f1f2d7d4b229df1f4ceefe3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 9.68e-05 | 187 | 109 | 5 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 9.68e-05 | 187 | 109 | 5 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.68e-05 | 187 | 109 | 5 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.68e-05 | 187 | 109 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.93e-05 | 188 | 109 | 5 | 229108e7e3db49e1cfd747d69e338394139d95b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-05 | 188 | 109 | 5 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 189 | 109 | 5 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.02e-04 | 189 | 109 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 189 | 109 | 5 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.04e-04 | 190 | 109 | 5 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 190 | 109 | 5 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 190 | 109 | 5 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 190 | 109 | 5 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 190 | 109 | 5 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 190 | 109 | 5 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 190 | 109 | 5 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.04e-04 | 190 | 109 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 192 | 109 | 5 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 192 | 109 | 5 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-04 | 192 | 109 | 5 | 72f936f03bb9b58c1ccaaf8270c07f5bbf2ac355 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-04 | 192 | 109 | 5 | dac61f0b374f6f9476eedce97f341f26c1bc037c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 193 | 109 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 194 | 109 | 5 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 194 | 109 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.15e-04 | 194 | 109 | 5 | 22b87fe2bb84632ddcef8f1d7742021728e2246d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 196 | 109 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 196 | 109 | 5 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.24e-04 | 197 | 109 | 5 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 197 | 109 | 5 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.24e-04 | 197 | 109 | 5 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 197 | 109 | 5 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 198 | 109 | 5 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-04 | 199 | 109 | 5 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.34e-04 | 106 | 109 | 4 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.34e-04 | 106 | 109 | 4 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.34e-04 | 106 | 109 | 4 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.70e-04 | 44 | 109 | 3 | 405ac4aeee539322cfe661c7531248f81271be8d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.70e-04 | 44 | 109 | 3 | a2c99e8ca635590a1f167b68bc390e2aa01e26be | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.30e-04 | 122 | 109 | 4 | 489a01c71882be5a6d71a19d06574698988c20f6 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.30e-04 | 122 | 109 | 4 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-04 | 122 | 109 | 4 | 7dabf8b4c34a3714f45c3a99c1aa159e2d0b7e9c | |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 CHD9 USP17L10 CHD7 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 9.38e-29 | 69 | 112 | 18 | DOID:1682 (implicated_via_orthology) |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L3 USP17L15 USP17L8 USP17L13 | 5.47e-28 | 46 | 112 | 16 | DOID:5426 (implicated_via_orthology) |
| Disease | vital capacity | BNC2 HIVEP2 CHD7 EBF1 ZMIZ1 SIX4 JMJD1C CASZ1 ARMS2 TRIM66 ZNF106 ZNF263 DMRT2 ANGPT4 CAPRIN2 PATJ NFAT5 | 4.22e-06 | 1236 | 112 | 17 | EFO_0004312 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.57e-04 | 71 | 112 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | FEV/FEC ratio | BNC2 ASXL1 HIVEP2 ARHGEF28 SOX30 JMJD1C FAM83B SPTBN5 PPARGC1A ZNF106 ANAPC1 KCNN3 MYO15A PRDM16 | 2.33e-04 | 1228 | 112 | 14 | EFO_0004713 |
| Disease | CHARGE syndrome (implicated_via_orthology) | 2.96e-04 | 7 | 112 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | facial morphology measurement | 4.14e-04 | 466 | 112 | 8 | EFO_0007841 | |
| Disease | mean platelet volume | HIVEP2 PCDHGA9 SMURF1 CHD9 CHD7 EBF1 ZMIZ1 JMJD1C PTPRJ PRDM16 PCDHGA8 SMAD5 | 5.05e-04 | 1020 | 112 | 12 | EFO_0004584 |
| Disease | Antihypertensive use measurement | 5.36e-04 | 265 | 112 | 6 | EFO_0009927 | |
| Disease | Prostatic Neoplasms | 5.80e-04 | 616 | 112 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.80e-04 | 616 | 112 | 9 | C0376358 | |
| Disease | waist-hip ratio | EBF1 ZMIZ1 KCNB2 JMJD1C KIAA2013 TRIM66 SLC7A2 CAPRIN2 TRIM8 KCNN3 PATJ NFAT5 PRDM16 | 7.75e-04 | 1226 | 112 | 13 | EFO_0004343 |
| Disease | electrocardiography | 9.56e-04 | 530 | 112 | 8 | EFO_0004327 | |
| Disease | QRS duration | 9.86e-04 | 298 | 112 | 6 | EFO_0005055 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.08e-03 | 13 | 112 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | hypertension | 1.15e-03 | 307 | 112 | 6 | EFO_0000537 | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 1.26e-03 | 14 | 112 | 2 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.34e-03 | 57 | 112 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | bipolar disorder | 1.64e-03 | 577 | 112 | 8 | MONDO_0004985 | |
| Disease | lower body strength measurement | 1.65e-03 | 16 | 112 | 2 | EFO_0007999 | |
| Disease | cataract | 2.08e-03 | 141 | 112 | 4 | MONDO_0005129 | |
| Disease | C-reactive protein measurement | BNC2 ARHGEF28 CHD7 EBF1 ZMIZ1 KCNB2 ZNF106 SEC16A KCNN3 QSER1 PATJ NFAT5 | 2.12e-03 | 1206 | 112 | 12 | EFO_0004458 |
| Disease | venous thromboembolism, fibrinogen measurement | 2.14e-03 | 67 | 112 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | diet measurement, HOMA-B | 2.34e-03 | 19 | 112 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | migraine disorder | 2.46e-03 | 357 | 112 | 6 | MONDO_0005277 | |
| Disease | p-tau measurement | 2.62e-03 | 72 | 112 | 3 | EFO_0004763 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.70e-03 | 364 | 112 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | granulocyte count | 2.89e-03 | 254 | 112 | 5 | EFO_0007987 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TQRRFQQPQHHLTLS | 86 | P0C7Q2 | |
| HQSFQHLLRTLNQSS | 116 | P01011 | |
| LRSSQPNVSALHCQH | 731 | Q96PE1 | |
| LENSNPSSIHHFENI | 301 | Q6ZN30 | |
| SHCLDHINPNNNLVN | 1201 | Q86V15 | |
| PHSSENNSNLSRGHL | 551 | Q9C0C7 | |
| QANDHHPRNLSSPFI | 636 | P52569 | |
| HPSTNQNQTKLTHFD | 56 | Q9P2D1 | |
| RTFHALPSHFQQQLL | 271 | Q8IXJ9 | |
| HHTPDTRTQAQQTQD | 241 | Q96K21 | |
| HHQRPSGTQSIQAQL | 191 | Q2KHR3 | |
| AQNGSRHSQHSFLEP | 241 | A8MUP6 | |
| QLSPNHHFSLDVQTG | 171 | Q9Y5G5 | |
| HQEFLFVNQPHSSSQ | 21 | O75747 | |
| LHFLQCHSKNNSPQD | 276 | Q9UFC0 | |
| PHDSNSHRPQLQAFI | 1661 | Q8N1W1 | |
| FSSRSHQERLQNHPK | 1821 | Q9H1A4 | |
| NIQTSESHPLRQFHF | 1186 | Q12913 | |
| EISAPQNFQHRVHTS | 11 | Q9NQU5 | |
| PLSENHNNNTFLKHL | 706 | Q9BY89 | |
| PHTSVTDVTQNNFHN | 506 | P19823 | |
| SQHRQQTQALSPHQA | 3386 | Q9UKN7 | |
| SSLSHLALAHQQQQQ | 821 | Q15652 | |
| TLREHSNCSHQNPFL | 66 | O75752 | |
| QEHQLGNNTLSSHLQ | 91 | Q9UK85 | |
| HHNTPAQSFANRLAQ | 436 | Q5T0W9 | |
| EHITNHRNPSNNRQI | 111 | A6NKB5 | |
| HPSSRQGSQLNLNDH | 121 | Q9UGI6 | |
| QLSPNHHFSLNVQTG | 171 | Q9Y5G4 | |
| QHHLNSQVSLLSLNP | 251 | Q6ZU69 | |
| DNPHSHRIQNVVTSF | 101 | P55268 | |
| QHSQRHSSTNLLQEG | 476 | Q9UHC3 | |
| LQQSSHSQAQLFHPQ | 1061 | O94916 | |
| SHHLTISPQSGNFRQ | 226 | Q9H074 | |
| TQNHANHNHRIRTNP | 166 | Q9UBK2 | |
| SLNSNNFQILHSSHP | 331 | Q3L8U1 | |
| HEQLNNTSSSSPQHL | 521 | Q92953 | |
| TFHSLCHQQQLQNPA | 861 | Q9Y6J0 | |
| LRHNPFHSLFQQTLT | 466 | Q9Y5R5 | |
| APRHFHTQTQSLQQS | 296 | O75319 | |
| PNRARNNTHSNLHTS | 1026 | Q6Y7W6 | |
| PHELSTSQNDNAHLQ | 1276 | P49454 | |
| SQIQRHHNQSTAINL | 206 | Q14152 | |
| HHNQSTAINLNNPES | 211 | Q14152 | |
| LSQNHPDNRNETFSS | 151 | Q9UBX1 | |
| HNSSLLQDQQHSLRQ | 246 | Q9Y264 | |
| QATTVPSNHRNNHIR | 41 | Q5SZL2 | |
| RHHTAINFIANPEQS | 1126 | Q5VV63 | |
| RNHNQLPALANTSVH | 416 | Q9UH73 | |
| HSQHGESQRALSPLQ | 91 | Q6IMN6 | |
| LNTSSTNHQLPSEHQ | 196 | Q9H992 | |
| QISESNHLIHLSNTN | 251 | Q9NV70 | |
| PQFQADLSNLHLNRH | 201 | Q8N344 | |
| NALHSQAHRGLQFTP | 1176 | A6NKG5 | |
| FTDPSNLQRHIRSQH | 346 | Q9HAZ2 | |
| IFSQHLQNRLLPDHT | 216 | Q5JRX3 | |
| SHSFESANHPLLQQL | 171 | Q9UIU6 | |
| KTARTQQYPHLHQQN | 1851 | Q9HCD6 | |
| DHNNRTTQFTDPRLH | 326 | Q9HCE7 | |
| QSQHPAAHTVREQLQ | 1276 | Q9NRC6 | |
| QRFTGPSQTDTHQLH | 511 | O94993 | |
| HSLLVQFRNLSHNEP | 151 | Q99717 | |
| HQQLSDPSTFSQHQP | 2426 | Q8IWZ3 | |
| LIFELNPRSNLSHQH | 301 | Q9UBH6 | |
| NPRSNLSHQHLFEIA | 306 | Q9UBH6 | |
| SQSLQQRSHHLENPF | 316 | Q5HYK9 | |
| SPLHHAQQLQLFSQQ | 891 | O15417 | |
| RNHQTHSFNLPLSQE | 156 | Q8N1K5 | |
| KNHHPEQQSSLLNLS | 476 | A6NCW0 | |
| FSNSSNLVQHQRIHT | 221 | Q6PDB4 | |
| SHHQQQAAQNSLLPL | 16 | Q14119 | |
| KNHHPEQQSSLLNLS | 476 | A6NCW7 | |
| AQTHSLLQHQPLQLT | 216 | Q7Z7H8 | |
| HLANNSDPESTFRQN | 291 | O15027 | |
| FTLQLPHSLHQTLQS | 66 | Q9UNN4 | |
| SQSLHDQQPHTQTAS | 311 | P08138 | |
| LAINHTPLDQNISHQ | 186 | Q8NI35 | |
| QLFLSPHQLQQHLRS | 316 | Q6ZN55 | |
| QSSNLTNHQRIHSGE | 586 | Q9Y2P7 | |
| KNHHPEQQSSLLNLS | 476 | D6R9N7 | |
| RHFQEHPRQQLATSS | 166 | O75425 | |
| KNHHPEQQSSLLNLS | 476 | A8MUK1 | |
| KNHHPEQQSSLLNLS | 476 | D6R901 | |
| KNHHPEQQSSLLNLS | 476 | C9JLJ4 | |
| QQPAQHHRDVLLSSS | 186 | Q9Y2X9 | |
| KNHHPEQQSSLLNLS | 476 | Q7RTZ2 | |
| FPNHTDNLNSSQRLS | 1306 | Q86X10 | |
| SSQQHQRPVLSFHVD | 131 | Q96L94 | |
| FNIPSSFQIHQRNHT | 131 | Q15973 | |
| SNLTNHQRIHSGQRP | 276 | Q86XU0 | |
| FDNQHSQDLDSRQHP | 1106 | Q07157 | |
| AFSQTSNLTQHQRIH | 551 | Q9BX82 | |
| SQSPQLTQHQRIHTG | 331 | Q9BRH9 | |
| KNHHPEQQSSLLNLS | 476 | Q0WX57 | |
| AFTQLSNLQSHQRQH | 321 | Q5T0B9 | |
| KNHHPEQQSSLLNLS | 476 | P0C7H9 | |
| KNHHPEQQSSLLNLS | 476 | P0C7I0 | |
| HQASLRQQEGHFLPS | 146 | Q6ZR37 | |
| QRERHHQPQTCTLSQ | 586 | Q70CQ4 | |
| QQSYHTQPRLVRQHN | 871 | P31629 | |
| QSHVQTHLQQPSTAR | 116 | Q9BZR9 | |
| QSHQSPVAQQEALSH | 291 | O15016 | |
| ILRTQNHILTNHPNS | 3496 | Q5T4S7 | |
| VSLSSHFLQQPQGHL | 581 | Q9C0B0 | |
| KNHHPEQQSSLLNLS | 476 | C9J2P7 | |
| KNHHPEQQSSLLNLS | 476 | D6RBQ6 | |
| KQHLLTDHTNPNFQT | 1831 | Q9H2Y7 | |
| FNHSPNPSKHQRNEI | 391 | O14628 | |
| KNHHPEQQSSLLNLS | 476 | Q6R6M4 | |
| KNHHPEQQSSLLNLS | 476 | D6RJB6 | |
| HLQNPANFHNAATEL | 21 | Q9ULJ6 | |
| KNHHPEQQSSLLNLS | 476 | C9JJH3 | |
| KNHHPEQQSSLLNLS | 476 | C9JVI0 | |
| TNLSQHQRTHTQERP | 206 | Q9UJN7 | |
| NFSNNSNLIRHQRIH | 386 | O14978 | |
| NHLQFQADPDVLHNS | 466 | Q8IYS2 | |
| NRFLHPQGSLTIQHA | 2786 | Q9NR99 | |
| QQHNSEHARLQVPTS | 211 | Q9UBF9 |